Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,866
Sort by:
2017 Poland Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Portugal Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Romania Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Slovakia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Slovenia Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Sweden Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Switzerland Cancer Diagnostics Market: Emerging Cancer Diagnostics, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains—Test Volume and Sales Forecasts, Competitive Strategies, Opportunities for Suppliers
US$ 4,365.00
... opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... major cancer diagnostics tests; profiles leading market players and potential entrants; and suggests alternative market expansion strategies for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
535 pages
2017 Europe Cancer Diagnostics Market Segmentation Analysis: Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 17,730.00
... market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market ... of laboratories performing cancer diagnostic testing by country. Cancer statistics, etiology and recent developments in Europe. Business ...
March 2017
820 pages
2017 Germany Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,030.00
... markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Germany. Business ...
March 2017
585 pages
2017 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 8,820.00
... US cancer diagnostics market during the nextfive years. The report examines trends in the US market; reviews current and emerging assays; analyzes potential applications of new diagnostic ... markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
March 2017
620 pages
Opportunity in Breast Cancer Therapeutics in Global Market - 2017
US$ 4,500.00
This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details the value chain, Players’ ...
March 2017
50 pages
Opportunity in Cancer Biomarkers Market in Global Market - 2017
US$ 4,500.00
... current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details ...
March 2017
50 pages
Opportunity in Cancer Supportive Care Products in Global Market - 2017
US$ 4,500.00
This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details the value chain, Players’ ...
March 2017
50 pages
Opportunity in Colorectal Cancer Therapeutics in Global Market - 2017
US$ 4,500.00
This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details the value chain, Players’ ...
March 2017
50 pages
Opportunity in Liver Cancer Therapeutics in Global Market - 2017
US$ 4,500.00
This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details the value chain, Players’ ...
March 2017
50 pages
Opportunity in Lung Cancer Therapeutics in Global Market - 2017
US$ 4,500.00
This report provides insight into the current market scenario, structure and practices. In depth market scenario includes: Current market size estimate Revenues by players - Top 5 Companies Market size by product categories Market size by regions/country Market structure details the value chain, Players’ ...
March 2017
50 pages
Global Cancer Biomarkers Market Research and Analysis 2015-2022
US$ 3,495.00
... global cancer biomarkers market. Geographical Insights Global Cancer biomarkers market can be segmented geographically into North America, Asia Pacific, Europe and RoW. In 2016, North America leads the global cancer biomarkers market ...
March 2017
Colorectal Cancer Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
... included at a country level across the 10-year forecast snapshot. Main symptoms and co-morbidities for Colorectal Cancer include: Change in bowel habits, including diarrhoea ... on the impact from specific co-morbid conditions on Colorectal Cancer incident population. Identify sub-populations within Colorectal Cancer which require treatment. Gain an understanding of the ...
February 2017
90 pages
Oesophageal Cancer Forecast in 18 Major Markets 2017-2027
US$ 6,150.00
... tumours of the oesophagus are responsible for the majority of oesophageal cancers. The majority of oesophageal cancers can be subdivided into two main histological subtypes: Adenocarcinomas ... level across the 10-year forecast snapshot. There are several features associated with the development and progression of oesophageal cancer, these include: Fistula ...
February 2017
70 pages
China Cervical Cancer Vaccine Market Research Report Forecast 2017-2021
US$ 2,480.00
The China Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview with ... market include: MSD GSK company 3 company 4 company 5 company 6 company 7 company 8 company 9 China Cervical Cancer Vaccine Market: Product Segment Analysis Type I Type II Type III China Cervical Cancer Vaccine Market: Application ...
February 2017
112 pages
Europe Cervical Cancer Vaccine Market Research Report Forecast 2017-2021
US$ 3,040.00
The Europe Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview with ... in the market include: MSD GSK company 3 company 4 company 5 company 6 company 7 company 8 company 9 Europe Cervical Cancer Vaccine Market Analysis by Product: Type I Type II Type III Europe Cervical Cancer Vaccine Market Analysis ...
February 2017
112 pages
Global Cervical Cancer Vaccine Market Professional Survey Report Forecast 2017-2021
US$ 2,720.00
This report studies Cervical Cancer Vaccine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and ... to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering MSD GSK ...
February 2017
112 pages
Global Cervical Cancer Vaccine Market Research Report Forecast 2017-2021
US$ 2,240.00
The Global Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview with ... market include: MSD GSK company 3 company 4 company 5 company 6 company 7 company 8 company 9 Global Cervical Cancer Vaccine Market: Product Segment Analysis Type I Type II Type III Global Cervical Cancer Vaccine Market: Application ...
February 2017
112 pages
Global Cervical Cancer Vaccine Sales Market Report Forecast 2017-2021
US$ 3,040.00
The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of ...
February 2017
112 pages
United States Cervical Cancer Vaccine Market Research Report Forecast 2017-2021
US$ 2,960.00
The United States Cervical Cancer Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cervical Cancer Vaccine industry overview ... 4 company 5 company 6 company 7 company 8 company 9 United States Cervical Cancer Vaccine Market: Product Segment Analysis Type I Type II Type III United States Cervical Cancer Vaccine Market: Application Segment Analysis Application ...
February 2017
112 pages
Pancreatic Cancer Treatment Market Analysis By Affected Region (Exocrine, Endocrine), By Type (Chemotherapy, Targeted Therapy, Others), By Region (North America, Europe, Asia Pacific, Latin America And MEA), And Segment Forecasts, 2014 - 2025
US$ 5,950.00
The global pancreatic cancer treatment market is expected to reach USD 4.2 billion in 2025, according to a new report by Grand ... growing awareness pertaining to various treatment options available are propelling the market growth at a global level. The peak incidence of pancreatic cancer is seen in the age ...
February 2017
90 pages
Global Breast Cancer Screening (Mammography, MRI and Ultrasound) Market and Population Forecast to 2022
US$ 1,990.00
... top contributors to the global breast cancer screening population. This is the 2nd edition report on breast cancer screening market by iGATE RESEARCH. The report titled “Global Breast Cancer Screening (Mammography, MRI and Ultrasound ... Screening Population and Forecast 5. Breast Cancer Mammography Screening Market and Forecast 6. Breast Cancer MRI Screening Market and Forecast 7. Breast Cancer Ultrasound Screening Market and Forecast 8. Global Breast Cancer Screening Market - Drivers and Challeng
February 2017
532 pages
Personalized Cancer Vaccines Market & Clinical Innovation Outlook 2022
US$ 2,000.00
... Personalized Cancer Vaccines Identification of Tumor Neoantigens Development & Mechanism of Personalized Vaccines Categories of Personalized Cancer Vaccines Biomarkers for Personalized Vaccines Personalized Vaccines for Multiple Cancers Current & Future Market Outlook of Personalized Cancer Vaccines ...
February 2017
170 pages
US Cancer Generics Market Outlook 2022
US$ 1,500.00
... . “US Cancer Generics Market Outlook 2022” report gives comprehensive insight on the various indicators and trend analysis related to the emergence and integration of cancer generics drugs in mainstream pharmaceutical market ...
February 2017
100 pages
